+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents & Consumables, Software & AI Solutions), Technique (Imaging, Molecular Diagnostics), Cancer Type, End Use, and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 130 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 6176791
REQUEST CUSTOMIZATION
Description Jump to:
The Brain cancer diagnostics market size was valued at USD 1.70 Billion in 2025 and is expected to reach USD 3.06 billion by 2033, growing at a CAGR of 7.60% from 2025 to 2033. The market growth is driven by the rising global incidence of primary and metastatic brain tumors, coupled with the need for early and accurate detection to guide complex treatment decisions.

Growing adoption of advanced imaging modalities (MRI, PET-MRI), integration of molecular profiling into WHO and NCCN guidelines, and the increasing role of AI-enabled platforms are fueling market growth. In addition, expanding reimbursement for DNA methylation profiling and heightened patient advocacy initiatives are accelerating access, standardization, and demand for innovative diagnostic solutions.

The global brain cancer diagnostics industry represents a high-value, high-need opportunity at the intersection of oncology and advanced diagnostics. Although brain cancers account for just ~2% of all cancers, they rank among the most burdensome malignancies worldwide, driving the fourth highest number of years of life lost across cancers. Treatment costs are exceptionally high, and patients typically undergo lifelong surveillance and follow-up scans. Importantly, until recently, brain tumors were the leading cause of cancer-related death among pediatric and young adult patients, underscoring the unmet medical need.

From a market perspective, this unique disease burden translates into sustained demand for diagnostics. The clinical reality is that therapeutic innovation in brain tumors has lagged behind other cancers; as a result, patient management is disproportionately dependent on accurate, repeated, and advanced diagnostics.

Global Brain Cancer Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the brain cancer diagnostics market report based on cancer type, product, technique, end use, and region:

Technique Outlook (Revenue, USD Million, 2021-2033)

  • Imaging
  • Tissue Sampling / Biopsy
  • Molecular Diagnostics
  • Others

Product Outlook (Revenue, USD Million, 2021-2033)

  • Instruments & Systems
  • Reagents & Consumables
  • Software & AI Solutions

Cancer Type Outlook (Revenue, USD Million, 2021-2033)

  • Gliomas
  • Meningiomas
  • Pituitary Tumors
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Oncology Treatment Centers
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Cancer Type and Product Snapshot
2.3. Technique and End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Technique Business Analysis
4.1. Brain Cancer Diagnostics Market: Technique Movement Analysis, 2024 & 2033
4.2. Imaging
4.2.1. Imaging Market, 2021-2033 (USD Million)
4.2.2. MRI
4.2.2.1. MRI market, 2021-2033 (USD million)
4.2.3. Computed Tomography (CT) Scan
4.2.3.1. Computed Tomography (CT) Scan market, 2021-2033 (USD million)
4.2.4. PET
4.2.4.1. PET market, 2021-2033 (USD million)
4.2.5. Single-Photon Emission Computed Tomography (SPECT) Scan
4.2.5.1. Single-Photon Emission Computed Tomography (SPECT) Scan market, 2021-2033 (USD million)
4.3. Tissue Sampling / Biopsy
4.3.1. Tissue Sampling / Biopsy Market, 2021-2033 (USD Million)
4.4. Molecular Diagnostics
4.4.1. Molecular Diagnostics Market, 2021-2033 (USD Million)
4.5. Others
4.5.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Product Business Analysis
5.1. Brain Cancer Diagnostics Market: Product Movement Analysis, 2024 & 2033
5.2. Instruments & Systems
5.2.1. Instruments & Systems Market, 2021-2033 (USD Million)
5.3. Reagents & Consumables
5.3.1. Reagents & Consumables market, 2021-2033 (USD million)
5.4. Software & AI Solutions
5.4.1. Software & AI Solutions market, 2021-2033 (USD million)
Chapter 6. Cancer Type Business Analysis
6.1. Brain Cancer Diagnostics Market: Cancer Type Movement Analysis, 2024 & 2033
6.2. Gliomas
6.2.1. Gliomas Market, 2021-2033 (USD Million)
6.3. Meningiomas
6.3.1. Meningiomas market, 2021-2033 (USD million)
6.4. Pituitary Tumors
6.4.1. Pituitary Tumors market, 2021-2033 (USD million)
6.5. Others
6.5.1. Others market, 2021-2033 (USD million)
Chapter 7. End Use Business Analysis
7.1. Brain Cancer Diagnostics Market: End Use Movement Analysis, 2024 & 2033
7.2. Hospitals
7.2.1. Hospitals Market, 2021-2033 (USD Million)
7.3. Oncology Treatment Centers
7.3.1. Oncology Treatment Centers Market, 2021-2033 (USD Million)
7.4. Others
7.4.1. Others Market, 2021-2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Competitive Scenario
8.3. Europe
8.3.1. Europe Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.2. Germany
8.3.2.1. Germany Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Competitive Scenario
8.3.3. UK
8.3.3.1. UK Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Competitive Scenario
8.3.4. France
8.3.4.1. France Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Competitive Scenario
8.3.5. Italy
8.3.5.1. Italy Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Competitive Scenario
8.3.6. Spain
8.3.6.1. Spain Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Competitive Scenario
8.4. Asia-Pacific
8.4.1. Asia-Pacific Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Competitive Scenario
8.4.3. China
8.4.3.1. China Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Competitive Scenario
8.4.4. India
8.4.4.1. India Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Competitive Scenario
8.4.6. Australia
8.4.6.1. Australia Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Competitive Scenario
8.4.7. Thailand
8.4.7.1. Thailand Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.5.2. Key Country Dynamics
8.5.3. Regulatory Framework
8.5.4. Competitive Scenario
8.5.5. Brazil
8.5.5.1. Brazil Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.5.5.2. Key Country Dynamics
8.5.5.3. Regulatory Framework
8.5.5.4. Competitive Scenario
8.5.6. Argentina
8.5.6.1. Argentina Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.5.6.2. Key Country Dynamics
8.5.6.3. Regulatory Framework
8.5.6.4. Competitive Scenario
8.6. MEA
8.6.1. MEA Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Brain Cancer Diagnostics Market, 2021-2033 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Acquisition
9.2.2. Collaborations
9.2.3. New Platform Launches
9.2.4. Others
9.3. Company Profiles/Listing
9.3.1. Hologic Inc.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Platform Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. GE Healthcare
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Platform Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Siemens Healthineers
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Platform Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Philips Healthcare
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Platform Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Thermo Fisher Scientific
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Platform Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Illumina, Inc.
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Platform Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Agilent Technologies
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Platform Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Bio-Rad Laboratories
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Platform Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Abbott Laboratories
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Platform Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. F. Hoffmann-La Roche Ltd.
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Platform Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 4 Global Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 5 Global Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 6 Global Brain Cancer Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 7 Global Brain Cancer Diagnostics Market, by Region, 2021-2033 (USD Million)
Table 8 North America Brain Cancer Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 9 North America Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 10 North America Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 11 North America Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 12 North America OTC U.S Brain Cancer Diagnostics Market, by End Use, 2021-2033 (USD Million)
Table 13 U.S Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 14 U.S Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 15 U.S Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 16 U.S Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 17 Canada Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 18 Canada Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 19 Canada Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 20 Canada Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 21 Mexico Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 22 Mexico Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 23 Mexico Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 24 Mexico Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 25 Europe Brain Cancer Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 26 Europe Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 27 Europe Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 28 Europe Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 29 Europe Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 30 UK Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 31 UK Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 32 UK Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 33 UK Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 34 Germany Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 35 Germany Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 36 Germany Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 37 Germany Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 38 France Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 39 France Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 40 France Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 41 France Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 42 Italy Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 43 Italy Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 44 Italy Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 45 Italy Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 46 Spain Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 47 Spain Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 48 Spain Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 49 Spain Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 50 Norway Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 51 Norway Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 52 Norway Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 53 Norway Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 54 Sweden Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 55 Sweden Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 56 Sweden Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 57 Sweden Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 58 Denmark Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 59 Denmark Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 60 Denmark Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 61 Denmark Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 62 Asia-Pacific Brain Cancer Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 63 Asia-Pacific Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 64 Asia-Pacific Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 65 Asia-Pacific Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 66 Asia-Pacific Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 67 Japan Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 68 Japan Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 69 Japan Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 70 Japan Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 71 China Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 72 China Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 73 China Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 74 China Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 75 India Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 76 India Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 77 India Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 78 India Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 79 Australia Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 80 Australia Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 81 Australia Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 82 Australia Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 83 South Korea Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 84 South Korea Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 85 South Korea Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 86 South Korea Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 87 Thailand Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 88 Thailand Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 89 Thailand Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 90 Thailand Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 91 Latin America Brain Cancer Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 92 Latin America Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 93 Latin America Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 94 Latin America Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 95 Latin America Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 96 Brazil Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 97 Brazil Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 98 Brazil Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 99 Brazil Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 100 Argentina Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 101 Argentina Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 102 Argentina Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 103 Argentina Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 104 Middle East Africa Brain Cancer Diagnostics Market, by Country, 2021-2033 (USD Million)
Table 105 Middle East Africa Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 106 Middle East Africa Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 107 Middle East Africa Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 108 Middle East Africa Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 109 South Africa Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 110 South Africa Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 111 South Africa Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 112 South Africa Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 113 Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 114 Saudi Arabia Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 115 Saudi Arabia Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 116 Saudi Arabia Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 117 UAE Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 118 UAE Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 119 UAE Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 120 UAE Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
Table 121 Kuwait Brain Cancer Diagnostics Market, by Cancer Type, 2021-2033 (USD Million)
Table 122 Kuwait Brain Cancer Diagnostics Market, by Product, 2021-2033 (USD Million)
Table 123 Kuwait Brain Cancer Diagnostics Market, by Technique, 2021-2033 (USD Million)
Table 124 Kuwait Brain Cancer Diagnostics Market by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Market Segmentation
Figure 8 Market Snapshot, 2024
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration & Growth Prospect Mapping, 2024
Figure 15 Global Brain Cancer Diagnostics Market: Technique Movement Analysis
Figure 16 Global Imaging Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 17 Global MRI Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 18 Global Computed Tomography (CT) Scan Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 19 Global PET Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 20 Global Single-Photon Emission Computed Tomography (SPECT) Scan Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 21 Global Tissue Sampling / Biopsy Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Global Molecular Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Global Other Tests Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Global Brain Cancer Diagnostics Market: Product Movement Analysis
Figure 25 Global Instruments & Systems Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Global Reagents & Consumables Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Global Software & AI Solutions Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Global Brain Cancer Diagnostics Market: Cancer Type Movement Analysis
Figure 29 Global Gliomas Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 Global Meningiomas Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Global Pituitary Tumors Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 32 Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 Global Brain Cancer Diagnostics Market: End Use Movement Analysis
Figure 34 Global Hospitals Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Global Oncology Treatment Centers Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Global Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Regional Marketplace: Key Takeaways
Figure 38 Regional Outlook, 2024 & 2033
Figure 39 Global Brain Cancer Diagnostics Market: Regional Movement Analysis
Figure 40 North America Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 41 U.S Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Canada Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Mexico Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Europe Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Germany Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 UK Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 France Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 48 Italy Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 49 Spain Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 50 Denmark Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Sweden Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 52 Norway Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Asia-Pacific Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 54 Japan Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 China Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 56 India Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 Australia Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 58 South Korea Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Thailand Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Latin America Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 Brazil Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Argentina Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 63 Middle East And Africa Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 South Africa Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 65 Saudi Arabia Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 66 UAE Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 67 Kuwait Brain Cancer Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)

Companies Mentioned

The leading players profiled in this Brain Cancer Diagnostics market report include:
  • ologic Inc.
  • E Healthcare
  • iemens Healthineers
  • hilips Healthcare
  • hermo Fisher Scientific
  • llumina, Inc.
  • gilent Technologies
  • io-Rad Laboratories
  • bbott Laboratories
  • . Hoffmann-La Roche Ltd.

Table Information

Report AttributeDetails
No. of Pages130
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 1.7 Billion
Forecasted Market Value ( USD ) by 2033 $ 3.06 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Advanced Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test (Tumor Marker Tests, Fine Needle Aspiration Cytology (FNAC) & Biopsy, Imaging-Based Diagnostics, Bone Marrow Aspiration & Biopsy), End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Advanced Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test (Tumor Marker Tests, Fine Needle Aspiration Cytology (FNAC) & Biopsy, Imaging-Based Diagnostics, Bone Marrow Aspiration & Biopsy), End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Global
From
Canada Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others - Product Image

Canada Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • Report
  • 158 Pages
  • Canada
From
Body Fluid Collection and Diagnostics Market Size, Share & Trends Analysis Report by Sample (Blood, Saliva, Urine, Cerebrospinal Fluid), Product (Tests/Services), Technology, Application, and Region with Growth Forecasts, 2025-2033 - Product Image

Body Fluid Collection and Diagnostics Market Size, Share & Trends Analysis Report by Sample (Blood, Saliva, Urine, Cerebrospinal Fluid), Product (Tests/Services), Technology, Application, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Cancer Diagnostics Global Market Opportunities and Strategies to 2033 - Product Image

Cancer Diagnostics Global Market Opportunities and Strategies to 2033

  • Report
  • 313 Pages
  • Global
From
Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Papillary Carcinoma, Follicular Carcinoma), Technique (Imaging, Biopsy), End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report by Cancer Type (Papillary Carcinoma, Follicular Carcinoma), Technique (Imaging, Biopsy), End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.